US4349552A
(en)
|
1978-10-30 |
1982-09-14 |
Fujisawa Pharmaceutical Company, Ltd. |
5-Fluorouracil derivatives, and their pharmaceutical compositions
|
NZ221717A
(en)
|
1986-09-10 |
1990-08-28 |
Sandoz Ltd |
Azaindole and indolizine derivatives and pharmaceutical compositions
|
MX19185A
(es)
|
1989-01-20 |
1993-12-01 |
Pfizer |
Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
FR2687402B1
(fr)
|
1992-02-14 |
1995-06-30 |
Lipha |
Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
|
DE4304455A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
IL129871A
(en)
|
1994-05-06 |
2003-11-23 |
Pharmacia & Upjohn Inc |
Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
|
US6075037A
(en)
|
1994-06-09 |
2000-06-13 |
Smithkline Beecham Corporation |
Endothelin receptor antagonists
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
GB9721437D0
(en)
|
1997-10-10 |
1997-12-10 |
Glaxo Group Ltd |
Heteroaromatic compounds and their use in medicine
|
US6313126B1
(en)
|
1999-01-07 |
2001-11-06 |
American Home Products Corp |
Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
|
AU2494300A
(en)
|
1999-01-07 |
2000-07-24 |
American Home Products Corporation |
3,4-dihydro-2h-benzo(1,4)oxazine derivatives
|
EP1147083B1
(fr)
|
1999-01-07 |
2004-06-16 |
Wyeth |
Derives d'indole arylpiperazinyl-cyclohexyle pour le traitement des depressions
|
US6265403B1
(en)
|
1999-01-20 |
2001-07-24 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
AR028475A1
(es)
|
1999-04-22 |
2003-05-14 |
Wyeth Corp |
Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
|
US20030153560A1
(en)
|
1999-04-23 |
2003-08-14 |
Salituro Francesco G. |
Inhibitors of c-Jun N-terminal kinases (JNK)
|
WO2001001986A1
(fr)
|
1999-07-02 |
2001-01-11 |
Lipton Stuart A |
Procede pour reduire une blessure neuronale ou empecher l'apoptose
|
GB9919843D0
(en)
|
1999-08-20 |
1999-10-27 |
Smithkline Beecham Plc |
Novel compounds
|
DE19948417A1
(de)
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
AU2735201A
(en)
|
1999-12-28 |
2001-07-09 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
CA2400447C
(fr)
|
2000-02-17 |
2008-04-22 |
Amgen Inc. |
Inhibiteurs de kinases
|
US7041277B2
(en)
|
2000-03-10 |
2006-05-09 |
Cadbury Adams Usa Llc |
Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
|
CA2308994A1
(fr)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Composes neuroprotecteurs
|
WO2002014317A2
(fr)
|
2000-08-14 |
2002-02-21 |
Ortho Mcneil Pharmaceutical, Inc. |
Pyrazoles substitues
|
US6369032B1
(en)
|
2000-09-06 |
2002-04-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for treating allergies
|
CN1321641C
(zh)
|
2000-09-06 |
2007-06-20 |
奥索-麦克尼尔药品公司 |
取代的吡唑在制备用于治疗***反应的药物中的应用
|
AR031130A1
(es)
|
2000-09-20 |
2003-09-10 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
KR20030062442A
(ko)
|
2000-12-22 |
2003-07-25 |
와이어쓰 |
5-하이드록시트립타민-6-리간드로서의 헤테로사이클인다졸및 아자인다졸 화합물
|
US20030165873A1
(en)
|
2001-03-02 |
2003-09-04 |
Come Jon H. |
Three hybrid assay system
|
SI1392697T1
(en)
|
2001-03-14 |
2005-02-28 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f)quinoline
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
AU2002258971A1
(en)
|
2001-04-24 |
2002-11-05 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
|
US6656950B2
(en)
|
2001-04-25 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
|
CN1267434C
(zh)
|
2001-04-26 |
2006-08-02 |
惠氏公司 |
抗抑郁的(SSSRI)7,8-二氢-3H-6,9-二氧杂-1,3-二氮杂环戊二烯并[a]萘的氮杂环基甲基衍生物
|
US6593350B2
(en)
|
2001-04-26 |
2003-07-15 |
Wyeth |
Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
|
JP2004527563A
(ja)
|
2001-04-26 |
2004-09-09 |
ワイス |
抗うつ作用を有する、2,3−ジヒドロ−1,4−ジオキシノ[2,3−f]キノキサリンのアザへテロシクリルメチル誘導体
|
US6656947B2
(en)
|
2001-04-26 |
2003-12-02 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
|
JP2004532236A
(ja)
|
2001-04-26 |
2004-10-21 |
ワイス |
抗うつ作用を持つ、オキサヘテロ環結合[1、4]−ベンゾジオキサンのアザヘテロシクリルメチル誘導体
|
DK1392700T3
(da)
|
2001-04-30 |
2004-10-25 |
Wyeth Corp |
Antidepressive azaheterocyclylmethylderivater af 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalen
|
US6555560B2
(en)
|
2001-04-30 |
2003-04-29 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
|
GB0111186D0
(en)
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
CA2447150A1
(fr)
|
2001-05-17 |
2002-11-21 |
Wyeth |
Procedes de synthese de derives de 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
|
JP4541695B2
(ja)
|
2001-06-15 |
2010-09-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターとしての5−(2−アミノピリミジン−4−イル)ベンズイソキサゾール
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2003010169A1
(fr)
|
2001-07-25 |
2003-02-06 |
Wyeth |
Derives azaheterocyclylmethyles de 7,8-dihydro-6h-5-oxa-1-aza-phenanthrene, a effet antidepresseur
|
US20040236110A1
(en)
|
2001-09-26 |
2004-11-25 |
Ladouceur Gaetan H |
Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
|
US6667322B2
(en)
|
2001-10-05 |
2003-12-23 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole
|
US7361671B2
(en)
|
2001-11-15 |
2008-04-22 |
The Institute For Pharmaceutical Discovery, Inc. |
Substituted heteroarylalkanoic acids
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
AU2003237121A1
(en)
|
2002-04-26 |
2003-11-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
MXPA04010545A
(es)
|
2002-04-26 |
2005-01-25 |
Pfizer Prod Inc |
Inhibidores de metaloproteinasa de heteroariloxi-aril-espiero-pirimidina-2,4,6-triona n-sustituida.
|
IL164209A0
(en)
|
2002-05-31 |
2005-12-18 |
Eisai Co Ltd |
Pyrazole derivatives and pharmaceutical compositions containing the same
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
CN1319968C
(zh)
|
2002-08-02 |
2007-06-06 |
沃泰克斯药物股份有限公司 |
用作gsk-3的抑制剂的吡唑组合物
|
AU2002368154A1
(en)
|
2002-08-08 |
2004-02-25 |
Ribapharm Inc. |
Improved synthesis for hydroxyalkylated heterocyclic bases
|
SE0202463D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
US7262200B2
(en)
|
2002-10-25 |
2007-08-28 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
ATE361924T1
(de)
|
2003-02-26 |
2007-06-15 |
Boehringer Ingelheim Pharma |
Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
EP2295433A3
(fr)
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
Inhibiteurs de JNK
|
US7381825B2
(en)
|
2003-03-17 |
2008-06-03 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
WO2005000813A1
(fr)
|
2003-05-30 |
2005-01-06 |
Imclone Systems Incorporated |
Derives d'heteroarylamino-phenylcetone et leur utilisation en tant qu'inhibiteurs de kinases
|
WO2004106298A1
(fr)
|
2003-05-30 |
2004-12-09 |
Janssen Pharmaceutica N.V. |
Derive d'indole a activite antipsychotique amelioree
|
CA2531232A1
(fr)
|
2003-07-16 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Derives de triazolopyrimidine en tant qu'inhibiteurs de glycogene synthase kinase 3
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
WO2005044181A2
(fr)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection de tissus et de cellules des effets cytotoxiques d'un rayonnement ionisant par des inhibiteurs abl
|
JP2007507529A
(ja)
|
2003-09-30 |
2007-03-29 |
サイオス・インコーポレーテツド |
複素環式アミドおよびスルホンアミド
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
CA2550361C
(fr)
|
2003-12-19 |
2014-04-29 |
Prabha Ibrahim |
Composes et methodes de developpement de modulateurs de ret
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
GB0405055D0
(en)
|
2004-03-05 |
2004-04-07 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
KR101216372B1
(ko)
|
2004-03-30 |
2013-01-04 |
버텍스 파마슈티칼스 인코포레이티드 |
Jak 및 기타 단백질 키나제의 억제제로서 유용한 아자인돌
|
US7514448B2
(en)
|
2004-04-02 |
2009-04-07 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of rock and other protein kinases
|
ITMI20040874A1
(it)
|
2004-04-30 |
2004-07-30 |
Ist Naz Stud Cura Dei Tumori |
Derivati indolici ed azaindolici con azione antitumorale
|
KR100476851B1
(ko)
|
2004-05-18 |
2005-03-17 |
(주)성신엔지니어링 |
중력식 섬유여과기
|
US20060058339A1
(en)
|
2004-06-17 |
2006-03-16 |
Ibrahim Prabha N |
Compounds modulating c-kit activity and uses therefor
|
DE102004029784A1
(de)
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
US7173031B2
(en)
|
2004-06-28 |
2007-02-06 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
US20060122213A1
(en)
|
2004-06-30 |
2006-06-08 |
Francoise Pierard |
Azaindoles useful as inhibitors of protein kinases
|
BRPI0513916A
(pt)
|
2004-07-27 |
2008-05-20 |
Sgx Pharmaceuticals Inc |
moduladores de pirrol-piridina cinase
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
JP5002460B2
(ja)
|
2004-10-04 |
2012-08-15 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
タンパク質キナーゼインヒビターとして有用なラクタム化合物
|
WO2006038001A1
(fr)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Derives d’aminopyrimidine en tant qu’inhibiteurs de la jnk
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
DK1812440T3
(da)
|
2004-11-04 |
2011-01-31 |
Vertex Pharma |
Pyrazolo[1,5-a]pyrimidiner, der kan anvendes som inhibistorer af proteinkinaser
|
MX2007006103A
(es)
|
2004-11-22 |
2007-07-20 |
Vertex Pharma |
Pirrolopirazinas y pirazolopirazinas de utilidad como inhibidores de proteinquinasas.
|
US20090233955A1
(en)
|
2004-12-08 |
2009-09-17 |
Frazee James S |
1H-Pyrrolo[2,3-B]Pyridnes
|
JP2008524233A
(ja)
|
2004-12-16 |
2008-07-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
炎症性疾患、増殖性疾患および免疫介在性疾患の治療のためのtecファミリータンパク質キナーゼのインヒビターとして有用なピリド−2−オン
|
US20060161001A1
(en)
|
2004-12-20 |
2006-07-20 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
ATE420883T1
(de)
|
2005-02-03 |
2009-01-15 |
Vertex Pharma |
Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
|
AU2006247322A1
(en)
|
2005-05-16 |
2006-11-23 |
Irm Llc |
Pyrrolopyridine derivatives as protein kinase inhibitors
|
ZA200710379B
(en)
|
2005-05-20 |
2009-05-27 |
Vertex Pharma |
Pyrrolopyridines useful as inhibitors of protein kinase
|
SI2395004T1
(sl)
|
2005-06-22 |
2016-05-31 |
Plexxikon Inc. |
Derivati piro (2,3-b) piridina kot inhibitorji proteinske kinaze
|
EP1749523A1
(fr)
|
2005-07-29 |
2007-02-07 |
Neuropharma, S.A. |
Des inhibiteurs de GSK-3
|
GB0516156D0
(en)
|
2005-08-05 |
2005-09-14 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
EP2532667A1
(fr)
|
2005-09-30 |
2012-12-12 |
Vertex Pharmaceuticals Incorporated |
Déazapurines convenant comme inhibiteurs de janus kinases
|
EP2514751A1
(fr)
|
2005-11-15 |
2012-10-24 |
Vertex Pharmaceuticals, Inc. |
Azaindazoles utiles en tant qu'inhibiteurs de kinases
|
US20130096302A1
(en)
|
2005-11-22 |
2013-04-18 |
Hayley Binch |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
CN104650077A
(zh)
|
2006-01-17 |
2015-05-27 |
沃泰克斯药物股份有限公司 |
适用作詹纳斯激酶抑制剂的吖吲哚类
|
TW200804389A
(en)
|
2006-02-14 |
2008-01-16 |
Vertex Pharma |
Dihydrodiazepines useful as inhibitors of protein kinases
|
US7659283B2
(en)
|
2006-02-14 |
2010-02-09 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases
|
DE102006012617A1
(de)
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
CA2648250A1
(fr)
|
2006-04-05 |
2007-10-18 |
Vertex Pharmaceuticals Incorporated |
Desazapurines utiles comme inhibiteurs des kinases janus
|
EP2032582A1
(fr)
|
2006-04-26 |
2009-03-11 |
F.Hoffmann-La Roche Ag |
Dérivés pyrimidiniques utilisés comme inhibiteurs de la pi3k
|
WO2007129195A2
(fr)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazoles
|
WO2007146057A2
(fr)
|
2006-06-09 |
2007-12-21 |
Wisconsin Alumni Research Foundation |
Procédé de criblage destiné à la détermination de modulateurs de la transcription ou de la réplication virale
|
CN101541783B
(zh)
|
2006-06-30 |
2014-10-01 |
苏尼西斯制药有限公司 |
吡啶酮基pdk1抑制剂
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
MX2009001451A
(es)
|
2006-08-08 |
2009-02-18 |
Chugai Pharmaceutical Co Ltd |
Derivado de pirimidina como inhibidor de pi3k y uso del mismo.
|
JP5534811B2
(ja)
|
2006-08-24 |
2014-07-02 |
アストラゼネカ アクチボラグ |
増殖性疾患の治療に有用なモルホリノピリミジン誘導体
|
US20130310418A1
(en)
|
2006-11-15 |
2013-11-21 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
JP5406725B2
(ja)
|
2006-12-14 |
2014-02-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
タンパク質キナーゼ阻害剤として有用な化合物
|
JP5406039B2
(ja)
|
2006-12-21 |
2014-02-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
タンパク質キナーゼ阻害剤として有用な5−シアノ−4−(ピロロ[2,3b]ピリジン−3−イル)−ピリミジン誘導体
|
TW200840581A
(en)
|
2007-02-28 |
2008-10-16 |
Astrazeneca Ab |
Novel pyrimidine derivatives
|
MX2009009590A
(es)
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de proteinas cinasas.
|
EP2134709A1
(fr)
|
2007-03-09 |
2009-12-23 |
Vertex Pharmaceuticals, Inc. |
Utilisation des aminopyridines comme inhibiteurs de protéines kinases
|
WO2008112651A2
(fr)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines utiles en tant qu'inhibiteurs des protéines kinases
|
AU2008228303B2
(en)
|
2007-03-22 |
2012-04-19 |
Takeda Pharmaceutical Company Limited |
Substituted pyrimidodiazepines useful as PLK1 inhibitors
|
RU2339637C1
(ru)
|
2007-04-05 |
2008-11-27 |
Андрей Александрович Иващенко |
Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием
|
RU2334747C1
(ru)
|
2007-04-05 |
2008-09-27 |
Андрей Александрович Иващенко |
ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
|
AR067762A1
(es)
|
2007-07-31 |
2009-10-21 |
Vertex Pharma |
Proceso para preparar 5-fluoro-1h-pirazolo (3,4-b) piridin-3-amina y derivados de la misma
|
JP5380447B2
(ja)
|
2007-08-15 |
2014-01-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
増殖性疾患の処置のための、ヒトタンパク質キナーゼplk1ないしplk4の阻害剤としての4−(9−(3,3−ジフルオロシクロペンチル)−5,7,7−トリメチル−6−オキソ−6,7,8,9−テトラヒドロ−5h−ピリミド[4,5−b[1,4]ジアゼパン−2−イルアミノ]−3−メトキシベンザミド誘導体
|
US8563542B2
(en)
|
2007-09-28 |
2013-10-22 |
Cyclacel Limited |
Pyrimidine derivatives as protein kinase inhibitors
|
AU2008309939B2
(en)
|
2007-10-09 |
2013-11-14 |
European Molecular Biology Laboratory (Embl) |
Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap
|
CA2704266A1
(fr)
|
2007-11-02 |
2009-06-11 |
Vertex Pharmaceuticals Incorporated |
Derives de [1h-pyrazolo[3,4-b]pyridin-4-yl]-phenyle ou -pyridin-2-yle en tant qu'inhibiteurs de la proteine kinase c-theta
|
BRPI0819223A2
(pt)
|
2007-11-05 |
2020-08-18 |
Novartis Ag |
derivados de 4-benzilamino-1-carboxiacil-piperidina como inibidores de cetp úteis para o tratamento de doenças tais como hiperlipidemia ou arteriosclerose
|
MX2010008198A
(es)
|
2008-02-25 |
2010-08-23 |
Hoffmann La Roche |
Inhibidores de cinasa de pirrolopirazina.
|
EP2262498A2
(fr)
|
2008-03-10 |
2010-12-22 |
Vertex Pharmceuticals Incorporated |
Pyrimidines et pyridines utiles comme inhibiteurs des protéines kinases
|
WO2009125395A1
(fr)
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anticorps antigrippe et leurs utilisations
|
CN102076690A
(zh)
|
2008-06-23 |
2011-05-25 |
维泰克斯制药公司 |
蛋白激酶抑制剂
|
CA2728830A1
(fr)
|
2008-06-23 |
2010-01-21 |
Jean-Damien Charrier |
Inhibiteurs de proteine kinase
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
CA2731496A1
(fr)
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de pyrazolopyridine kinase
|
ES2402087T3
(es)
|
2008-07-23 |
2013-04-26 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la pirazolopiridina quinasa
|
MX2011000837A
(es)
|
2008-07-23 |
2011-04-05 |
Vertex Pharma |
Inhibidores de pirazolpiridina cinasa triciclica.
|
CN102459259A
(zh)
|
2009-05-06 |
2012-05-16 |
沃泰克斯药物股份有限公司 |
吡唑并吡啶类
|
AU2010262905B2
(en)
|
2009-06-17 |
2015-04-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
WO2011000566A2
(fr)
|
2009-06-30 |
2011-01-06 |
Savira Pharmaceuticals Gmbh |
Composés et compositions pharmaceutiques pour le traitement de dinfections virales à arn simple brin, sens négatif
|
JP2012533553A
(ja)
|
2009-07-15 |
2012-12-27 |
アボット・ラボラトリーズ |
ピロロピリジン系キナーゼ阻害薬
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
HUE029611T2
(en)
|
2010-04-07 |
2017-03-28 |
Vertex Pharma |
3- (6- (1- (2,2-Difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) benzoic acid
|
WO2011130146A1
(fr)
|
2010-04-14 |
2011-10-20 |
Array Biopharma Inc. |
[1,2-c]pyrimidines 5,7-imidazo-substituées comme inhibiteurs de jak kinases
|
EP2563125A4
(fr)
|
2010-04-27 |
2013-10-02 |
Merck Sharp & Dohme |
Azaindoles comme inhibiteurs de janus kinase
|
CA2822057A1
(fr)
|
2010-12-16 |
2012-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de la replication des virus de la grippe
|
KR20130128436A
(ko)
|
2010-12-16 |
2013-11-26 |
버텍스 파마슈티칼스 인코포레이티드 |
인플루엔자 바이러스 복제의 억제제
|
CN103562205A
(zh)
|
2010-12-16 |
2014-02-05 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
NZ619699A
(en)
|
2011-07-05 |
2016-03-31 |
Vertex Pharma |
Processes and intermediates for producing azaindoles
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
AU2012336019A1
(en)
|
2011-11-07 |
2014-05-29 |
Vertex Pharmaceuticals Incorporated |
Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
|
WO2013184985A1
(fr)
|
2012-06-08 |
2013-12-12 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de la réplication de virus de la grippe
|
WO2014110259A1
(fr)
*
|
2013-01-09 |
2014-07-17 |
Vertex Pharmaceuticals Incorporated |
Formes solides d'un inhibiteur de jak
|
WO2014201332A1
(fr)
|
2013-06-14 |
2014-12-18 |
Vertex Pharmaceuticals Incorporated |
Combinaisons pharmaceutiques utiles pour traiter la polyarthrite rhumatoïde
|
CA2921198A1
(fr)
|
2013-08-22 |
2015-02-26 |
Vertex Pharmaceuticals Incorporated |
Azaindoles isotopiquement enrichis
|
KR102468319B1
(ko)
*
|
2013-09-12 |
2022-11-16 |
얀센 바이오파마, 인코퍼레이트. |
아자-피리돈 화합물 및 이의 용도
|
WO2015050170A1
(fr)
*
|
2013-10-02 |
2015-04-09 |
学校法人 久留米大学 |
Médicament d'inhibition du virus de la grippe
|
US9296727B2
(en)
|
2013-10-07 |
2016-03-29 |
Vertex Pharmaceuticals Incorporated |
Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
|
DK3068782T3
(en)
|
2013-11-13 |
2018-08-13 |
Vertex Pharma |
Methods for the preparation of inhibitors of influenza virus replication
|
CA2930105A1
(fr)
|
2013-11-13 |
2015-05-21 |
Vertex Pharmaceuticals Incorporated |
Formulations de composes aza-indole
|
EP3068776B1
(fr)
|
2013-11-13 |
2019-05-29 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de la réplication des virus de la grippe
|
BR112017002370B1
(pt)
|
2014-08-08 |
2022-11-22 |
Janssen Sciences Ireland Uc |
Compostos indóis, composição farmacêutica que os compreende e seu uso na inibição da replicação do vírus da gripe
|
LT3191489T
(lt)
|
2014-09-08 |
2021-01-25 |
Janssen Sciences Ireland Unlimited Company |
Pirolopirimidinai, skirti naudoti gripo viruso infekcijos atveju
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
CN108290869B
(zh)
|
2015-11-27 |
2021-05-18 |
爱尔兰詹森科学公司 |
用于在流感病毒感染中使用的杂环吲哚
|
JP7001601B2
(ja)
|
2016-01-07 |
2022-01-19 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
インフルエンザウイルス感染に使用するための官能化ペンタン酸
|
CA3010327A1
(fr)
|
2016-01-20 |
2017-07-27 |
Janssen Sciences Ireland Uc |
Pyrimidines a substitution aryle a utiliser dans une infection par le virus de la grippe
|
WO2017223231A1
(fr)
|
2016-06-21 |
2017-12-28 |
Alios Biopharma, Inc. |
(s)-8-(benzhydryl)-6-isopropyl-3,5-dioxo-5,6,7,8,-tétrahydro-3 h-pyrazino-[1,2-b] pyridazin-yl-isobutyrate, agent antiviral destiné à être utilisé dans le traitement de la grippe
|